Web23 nov. 2024 · Nineteen (17%) patients experienced an ITP exacerbation following the first dose and 14 (20%) of 70 after a second dose. In total, fifteen patients received and responded to rescue treatments (n = 6 after dose 1, n = 8 after dose 2, n = 1 after both doses). Of 7 patients who received rescue treatment after dose 1, ... WebITP (exacerbation, stable and remission) are shown in Fig 2. IgG APLA were consistently more prevalent in exacerbation than in stable or remission stages for all the six antigens tested (Fig 2A). Statistical analysis showed that positive tests for all the six antigens during exacerbation were significantly higher

Immune thrombocytopenia of childhood responsive to ... - PubMed

WebNational Center for Biotechnology Information WebITP exacerbation occurred independently of remission status, concurrent ITP treatment, or vaccine type. Safety of a second vaccine dose needs careful assessment. Keywords: … attikka tree

SARS-CoV-2 vaccination and ITP in patients with de novo or

Web10 mrt. 2024 · An “exacerbation of ITP” was defined as the development of any 1 or more of the following: (1) ≥50% decline in platelet count from prevaccination baseline; (2) … Web22 mrt. 2024 · Also, patients with ITP with exacerbation needed more frequent rescue medication prior to COVID-19 vaccination compared with patients with ITP without exacerbation. These data may suggest that the hardest-to-treat patients with chronic ITP are more susceptible to develop thrombocytopenia after vaccination in comparison with a … Web23 okt. 2024 · Both SARS-CoV-2 infection and vaccination have raised concern in immune-mediated diseases, including immune thrombocytopenic purpura (ITP) considering risk of de novo ITP development and ITP recurrence. Here, we report on data from a single-center retrospective–prospective collection aiming to evaluate platelet (plt) dynamics in patients … attiko alsos